260 related articles for article (PubMed ID: 26418031)
21. Unmasking of LPA1 receptor-mediated migration response to lysophosphatidic acid by interleukin-1β-induced attenuation of Rho signaling pathways in rat astrocytes.
Sato K; Horiuchi Y; Jin Y; Malchinkhuu E; Komachi M; Kondo T; Okajima F
J Neurochem; 2011 Apr; 117(1):164-74. PubMed ID: 21244430
[TBL] [Abstract][Full Text] [Related]
22. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling.
Xiang D; Wang D; He Y; Xie J; Zhong Z; Li Z; Xie J
Anticancer Drugs; 2006 Aug; 17(7):753-62. PubMed ID: 16926625
[TBL] [Abstract][Full Text] [Related]
23. Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines.
Yar Saglam AS; Alp E; Elmazoglu Z; Menevse S
Hum Exp Toxicol; 2016 May; 35(5):526-43. PubMed ID: 26183715
[TBL] [Abstract][Full Text] [Related]
24. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq.
Kim J; Keys JR; Eckhart AD
Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475
[TBL] [Abstract][Full Text] [Related]
25. Krüppel-like factor 5 incorporates into the β-catenin/TCF complex in response to LPA in colon cancer cells.
Guo L; He P; No YR; Yun CC
Cell Signal; 2015 May; 27(5):961-8. PubMed ID: 25683913
[TBL] [Abstract][Full Text] [Related]
26. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
27. Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma.
Sokolov E; Eheim AL; Ahrens WA; Walling TL; Swet JH; McMillan MT; Simo KA; Thompson KJ; Sindram D; McKillop IH
J Surg Res; 2013 Mar; 180(1):104-13. PubMed ID: 23182454
[TBL] [Abstract][Full Text] [Related]
28. Negative regulation of cell motile and invasive activities by lysophosphatidic acid receptor-3 in colon cancer HCT116 cells.
Fukui R; Tanabe E; Kitayoshi M; Yoshikawa K; Fukushima N; Tsujiuchi T
Tumour Biol; 2012 Dec; 33(6):1899-905. PubMed ID: 22763559
[TBL] [Abstract][Full Text] [Related]
29. Effects of lysophosphatidic acid on human colon cancer cells and its mechanisms of action.
Sun H; Ren J; Zhu Q; Kong FZ; Wu L; Pan BR
World J Gastroenterol; 2009 Sep; 15(36):4547-55. PubMed ID: 19777613
[TBL] [Abstract][Full Text] [Related]
30. MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.
Lee SJ; Ritter SL; Zhang H; Shim H; Hall RA; Yun CC
Gastroenterology; 2011 Mar; 140(3):924-34. PubMed ID: 21134377
[TBL] [Abstract][Full Text] [Related]
31. Lysophosphatidic acid (LPA) signaling via LPA
Takahashi K; Fukushima K; Onishi Y; Inui K; Node Y; Fukushima N; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2017 Jan; 483(1):652-657. PubMed ID: 27993681
[TBL] [Abstract][Full Text] [Related]
32. Rho kinases regulate corneal epithelial wound healing.
Yin J; Yu FS
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C378-87. PubMed ID: 18495812
[TBL] [Abstract][Full Text] [Related]
33. Autotaxin produced by stromal cells promotes LFA-1-independent and Rho-dependent interstitial T cell motility in the lymph node paracortex.
Katakai T; Kondo N; Ueda Y; Kinashi T
J Immunol; 2014 Jul; 193(2):617-26. PubMed ID: 24935929
[TBL] [Abstract][Full Text] [Related]
34. Lysophosphatidic acid increases the proliferation and migration of adipose‑derived stem cells via the generation of reactive oxygen species.
Kang S; Han J; Song SY; Kim WS; Shin S; Kim JH; Ahn H; Jeong JH; Hwang SJ; Sung JH
Mol Med Rep; 2015 Oct; 12(4):5203-10. PubMed ID: 26134517
[TBL] [Abstract][Full Text] [Related]
35. Role of lysophosphatidic acid and rho in glioma cell motility.
Manning TJ; Parker JC; Sontheimer H
Cell Motil Cytoskeleton; 2000 Mar; 45(3):185-99. PubMed ID: 10706774
[TBL] [Abstract][Full Text] [Related]
36. Proteomic identification of betaig-h3 as a lysophosphatidic acid-induced secreted protein of human mesenchymal stem cells: paracrine activation of A549 lung adenocarcinoma cells by betaig-h3.
Shin SH; Kim J; Heo SC; Kwon YW; Kim YM; Kim IS; Lee TG; Kim JH
Mol Cell Proteomics; 2012 Feb; 11(2):M111.012385. PubMed ID: 22159598
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device.
Yamauchi A; Yamamura M; Katase N; Itadani M; Okada N; Kobiki K; Nakamura M; Yamaguchi Y; Kuribayashi F
BMC Cancer; 2017 Mar; 17(1):234. PubMed ID: 28359316
[TBL] [Abstract][Full Text] [Related]
38. Lysophosphatidic Acid and IL-6 Trans-signaling Interact via YAP/TAZ and STAT3 Signaling Pathways in Human Trabecular Meshwork Cells.
Yemanyi F; Raghunathan V
Invest Ophthalmol Vis Sci; 2020 Nov; 61(13):29. PubMed ID: 33216119
[TBL] [Abstract][Full Text] [Related]
39. Lysophosphatidic acid regulates the proliferation and migration of olfactory ensheathing cells in vitro.
Yan H; Lu D; Rivkees SA
Glia; 2003 Oct; 44(1):26-36. PubMed ID: 12951654
[TBL] [Abstract][Full Text] [Related]
40. Suppression of the p53-dependent replicative senescence response by lysophosphatidic acid signaling.
Kortlever RM; Brummelkamp TR; van Meeteren LA; Moolenaar WH; Bernards R
Mol Cancer Res; 2008 Sep; 6(9):1452-60. PubMed ID: 18723828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
